Толерантность к физической нагрузке и качество жизни у больных хронической обструктивной болезнью легких
Диссертация
Практическая значимость работы. Результаты исследования показали, что оценка тяжести хронической обструктивной болезни легких только на основании объема форсированного выдоха за 1 секунду не дает, полной информации о больном и что в качестве методологических подходов к определению тяжести заболевания могут быть использованы такие инструменты, как оценка одышки в баллах по шкале Борга, 6-минутный… Читать ещё >
Содержание
- Список сокращений
- Глава 1. ОБЗОР ЛИТЕРАТУРЫ
- 1. 1. Физическая активность и толерантность к физической нагрузке у больных хронической обструктивной болезнью легких
- 1. 2. Местное и системное воспаление при хронической обструктивной болезни легких
- 1. 3. Качество жизни больных хронической обструктивной болезнью легких
- Глава 2. МАТЕРИАЛ И МЕТОДЫ ИССЛЕДОВАНИЯ
- 2. 1. Клиническая характеристика больных, включенных в исследование
- 2. 2. Методы исследования
- 2. 2. 1. Спирография.39'
- 2. 2. 2. Эхокардиография
- 2. 2. 3. Шестиминутный шаговый тест.39'
- 2. 2. 4. С-реактивный белок
- 2. 2. 5. Оценка индуцированной мокроты
- 2. 2. 6. Оценка качества жизни
- 2. 2. 7. Методы статистической обработки полученных результатов
- 3. 1. Толерантность к физической нагрузке у больных хронической обструктивной болезнью легких
- 3. 2. Показатели местного и системного воспаления у больных хронической обструктивной болезнью легких
- 3. 3. ВОБЕ-индекс у больных хронической обструктивной болезнью легких
- 3. 4. Качество жизни больных хронической обструктивной болезнью легких
- 3. 5. Влияние тиотропия бромида на толерантность к физической нагрузке и качество жизни больных хронической обструктивной болезнью легких
Список литературы
- Авдеев, С.Н. Применение метода индуцированной мокроты для оценки интенсивности воспаления дыхательных путей / С. Н. Авдеев, Э. Х. Анаев, А. Г. Чучалин // Пульмонология. 1998. — № 2. — С. 81−86.
- Авдеев, С.Н. ХОБЛ и сердечно-сосудистые заболевания: механизмы ассоциации / С. Н. Авдеев, Г. Е. Баймаканова // Пульмонология. — 2008. — № 1. — С. 5−13.
- Влияние тиотропия бромида на эффективность легочной реабилитации у больных хронической обструктивной болезнью легких / В. А. Игнатьев, О. Н. Титова, М. Д. Дидур и др. // Пульмонология. 2007. — № 1.-С. 88−94.
- Глобальная стратегия диагностики, лечения и профилактики хронической обструктивной болезни легких. Пересмотр 2008 г. / пер. с англ. под ред. А. Г. Чучалина М.: Издательский дом «Атмосфера», 2007. — 96с.
- Опыт длительного лечения тиотропия бромидом больных хронической обструктивной болезнью легких / В. А. Игнатьев, О. Н. Титова, М. А. Каменева и др. // Пульмонология. 2007. — № 2. — С. 74−78.
- Коморбидность при хронической обструктивной болезни легких / H.A. Кароли, Е. Е. Орлова, A.B. Маркова и др. // Терапевтический архив. 2008. -№ 3.-С. 20−23.
- Кароли, H.A. Хроническая обструктивная болезнь легких и кардиоваскулярная патология / H.A. Кароли, А. П. Ребров // Клиницист. -2007.-№ 2.-С. 13−19.
- Качество жизни больных хроническими обструктивными болезнями легких / Е. И. Шмелев, М. В. Беда, P.W. Jones и др. // Пульмонология. -1998.-№ 2.-С. 79−81.
- Качество жизни больных хронической обструктивной болезнью легких в России: результаты многоцентрового популяционного исследования
- Популяционные показатели качества жизни по опроснику SF-36 / В. Н. Амирджанова, Д. В. Горячев, Н. И. Коршунов и др. // Научно-практическая ревматология. 2008. — № 1. — С. 36−48.
- Пыцкий, В.И. Аллергические заболевания / В. И. Пыцкий, Н. В. Адрианова, А.В. Артомасова-М.: Триада-Х, 1999. 470с.
- Реброва, О.Ю. Статистический анализ медицинских данных. Применение пакета прикладных данных STATISTIC, А / 0: Ю. Реброва-М.: Медиа Сфера, 2003. 312с.
- Сенкевич, Н.Ю. Качество жизни предмет научных исследований в пульмонологии / Н. Ю. Сенкевич, А. С. Белевский // Тер. архив. — 2000. -№ 3. — С. 36−41.
- Сенкевич, Н.Ю. Четыре вопроса о качестве жизни / Н. Ю. Сенкевич, Ф. М. Ханова, К. В. Сафрыгин // Атмосфера. Пульмонология и аллергология. 2002. — № 4. — С. 26−28.
- Суховская, О.А. Исследование качества жизни при заболеваниях органов дыхания / О. А. Суховская, М. М. Илькович, В. А. Игнатьев // Пульмонология. 2003. — № 3. — С. 96−100.
- Трофименко, И.Н. Взаимосвязь клинико-функционального статуса и качества жизни у больных хронической обструктивной болезнью легких / И. Н. Трофименко, Б. А. Черняк // Сибирский консилиум. — 2008. -№ 1.-С. 48−52.
- Хроническая обструктивная болезнь легких / под ред. А. Г. Чучалина — М.: Атмосфера, 2008. 568с.
- Чикина, С.Ю. Внелабораторная оценка одышки и функционального статуса при бронхолегочной патологии / С. Ю. Чикина // Пульмонология. 2004. — № 5. — С. 98−108.
- Чикина, С.Ю. Принципы оценки одышки в практике пульмонолога / С. Ю. Чикина // Атмосфера. Пульмонология и аллергология. 2006. -№ 2. — С. 24−30.
- Чучалин, А.Г. ХОБЛ и сопутствующие заболевания / А. Г. Чучалин // Пульмонология. 2008. — № 2. — С. 5−14.
- A 4-year trial of tiotropium in chronic obstructive pulmonary disease / D.P. Tashkin, B. Celli, S. Senn et ali // N. Engl. J. Med. 2008. — V. 359. — P. 1543−1554.
- A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease / N.S. Hopkinson, R.C. Tennant, M.J. Dayer et al. // Respir. Res. 2007. — V. 8. — P. 25.
- A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain / S. Solway, D. Brooks, Y. Lacasse et al. // Chest. 2001. — V. 119. — P. 256−270.
- A self-complete measure for chronic airflow limitation: The St. George’s Respiratory Questionnaire / P.W. Jones, F.H. Quirk, C.M. Baveystock et al. // Am. Rev. Respir. Dis. 1992. -V. 145. — P. 1321−1327.
- A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis / S. Verma, C.H. Wang, S.H. Li et al. // Circulation. -2002. -V. 106. P. 913−919.
- Accelerometer use in physical activity: best practices and research recommendations /D.S. Ward, K.R. Evenson, A. Vaughn et al. // Med. Sei Sports Exerc. 2005. — V. 37. — P. 582−588.
- Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease / F. Pitta, T. Troosters, M.A. Spruit et al. // Arch. Phys. Med. Rehabil. 2005. — V. 86. — P. 19 791 985.
- Agusti, A. Neff lecture. Chronic obstructive pulmonary disease: a systemic disease / A. Agusti, A. Thomas // Proc. Am. Thorac. Soc. — 2006. — V. 3. -P. 478−481.
- Agusti, A. COPD as a systemic disease / A. Agusti, J.B. Soriano // COPD -2008.-V. 5.-P. 133−138.
- Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis / M. Saetta, A. Di Stefano, P. Maestrelli et al. // Clin. Exp. Allergy 1996. — V. 26. — P. 766−774.
- Ambrosino, N. Dyspnoea and its measurement / N. Ambrosino // Breathe. -2004.-V. l.-P. 101−107.
- Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status / T. Oga, K. Nishimura, M. Tsukino et al. // Am. J. Respir. Crit. Care Med. 2003. — V. 167. — P. 544−549.
- Are patients with COPD, more active after pulmonary rehabilitation? / F. Pitta, T. Troosters, V.S. Probst et al. // Chest. 2008. — V. 134. — P. 273 280.
- Assessment of airway inflammation: an overview / L.M. Fabbri, S. Durham, S.T. Holgate et al. // Eur. Respir. J. 1998. — V. 11. — P. 6−8.
- Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis / W.Q. Gan, S.F. Man, A. Senthilselvan et al. // Thorax. 2004. — V. 59. — P. 57Ф-580.
- ATS Statement: Guidelines for the Six-Minute Walk Test / Robert O. Crapo, Richard Casaburi, Allan L. Coates et al. // Am J Respir Crit Car Med. -2002.-V. 166.-P. 111−117.
- Bakke, P. S. Clinically important phenotypes of COPD / P. S. Bakke // ERS Annual Congress Barcelona, 2010.
- Balasubramanian, V.P. Chronic obstructive pulmonary disease: effects beyond the lungs / V.P. Balasubramanian, B. Varkey // Curr. Opin. Pulm. Med.-2006.-V. 12.-P. 106−112.
- Barbera, J.A. Pulmonary hypertension in chronic obstructive pulmonary disease / J.A. Barbera, V.I. Peinado, S. Santos // Eur. Respir. J. 2003. — V. 21.-P. 892−905.
- Barnes P., Celli B.R. Systemic manifestations and comorbidities of COPD / P. Barnes, B.R. Celli//Eur. Respir. J.-2009.-V. 33.-P. 1165−1185.
- Barnes, P.J. Mediators of chronic obstructive pulmonary disease / P.J. Barnes // Pharmacol. Rev. 2004. — V. 56. — P. 515−548.
- Beck, A.T. Anxiety Disorders and Phobias: A cognitive perspective / A.T. Beck, G. Emery, R. Greenberg New York: Basic Books, 2005. — 333p.
- Blacher, J. Large-artery stiffness, hypertension and cardiovascular risk in older patients / J. Blacher, M.E. Safar // Nat. Clin. Pract. Cardiovasc. Med. — 2005.-V. 2.-P. 45055.
- Brody, J.S. State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer / J.S. Brody, A. Spira // Proc. Am. Thorac. Soc. 2006. — V. 3. — P. 535−537.
- Bronchodilator efficacy of tiotropium in patients with mild to moderate COPD Электронный ресурс. / G. Johansson, A. Lindberg, K. Romberg et al. // Primary Care Res. J. — 2008. V. 17. — Электрон, дан. — Режим доступа: www. thepcrj .org.
- Brown, J.R. Cyclooxygenase-2 in lung carcinogenesis and chemoprevention: Roger S. Mitchell lecture / J.R. Brown, R.N. Du Bois // Chest. 2004. — V. 125.-P. 134−140.
- Burrows, B. Predictors of loss of lung function and mortality in obstructive lung diseases / B. Burrows // Eur. Respir. Rev. 1991. — V. 1. — P. 340−345.
- CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease / M. Saetta, A. Di Stefano, G. Turato et al. // Am. J. Respir. Crit. Care Med. 1998. — V. 157. — P. 822−826.
- CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease / M. Saetta, S. Baraldo, L. Corbino et al. // Am. J. Respir. Crit. Care Med.-1999.-V. 159.-P. 1605−1611.
- Celli, B.R. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper / B.R. Celli, W. MacNee // Eur. Respir. J. 2004. — V. 23. — P. 932−946.
- Cellular characteristics of sputum from patients with asthma and chronic bronchitis / P.G. Gibson, A. Girgis-Gabardo, M.M. Morris et al. // Thorax. -1989.-V. 44.-P. 693−699.
- Change in C-reactive protein levels and FEVi decline: a longitudinal population-based study / R. Shaaban, S. Kony, F. Driss et al. // Respir. Med. — 2006. V. 100.-P. 2112−2120.
- Characteristics of physical activities in daily life in chronic obstructive pulmonary disease / F. Pitta, T. Troosters, M.A. Spruit et al. // Am. J. Respir. Crit. Care Med. -2005. -V. 171. -P. 972−977.
- Chiarugi, V. Cox-2, iNOS and p53 as play-makers of tumor angiogenesis (review) / V. Chiarugi, L. Magnelli, O. Gallo // Int. J. Mol. Med. 1998. -V.2.-P. 715−719.
- Chronic Obstructive Pulmonary Disease Phenotypes / M.K. Han, A. Agusti, P.M. Calverley et al. // Am. J. Respir. Crit. Care Med. 2010 — V. 182 — P. 598−604.
- Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group / M. Ferrer, J. Alonso, J. Morera et al. // An. Int. Med. 1997. — V. 127.-P. 1072−1079.
- Complex chronic comorbidities of COPD / L. Fabbri, F. Luppi, B. Beghe et al. // Eur. Respir: J. 2008 — V. 31. — P: 204^-212.
- Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease / D. Saey, R. Debigare, P. Leblanc et al. // Am. J: Respir. Crit. Care Med. 2003. — V. 168. — P. 425130.
- Contribution of- clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level / S. Kathiresan, M.G. Larson, R.S. Vasan et al. // Circulation. 2006. — V. 113.-P: 1415−1423.
- COPD' and' incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program / S. Sidney, M. Sorel, C.P. Jr Quesenberry et al. // Chest. 2005. — V. 128. — P. 2068−2075.
- Cote, C.G. Impact of COPD exacerbations on patient-centered outcomes / C.G. Cote, L.J. Dordelly, B.R. Celli // Chest. 2007. — V. 131. — P. 696 704.
- C-reactive protein and body mass index predict outcome in end-stage respiratory failure / N.J.M. Cano, C. Pichard, H. Roth et al. // Chest. 2004. -V. 126.-P. 540−546.
- C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease / M. Dahl, J. Vestbo, P. Lange et al. // Am. J. Respir. Crit. Care Med. 2007. — V. 175. — P. 250−255.
- C-reactive protein in patients with COPD, control smokers, and nonsmokers / V.M. Pinto-Plata, H. Mullerova, J.F. Toso et al. // Thorax. 2006. — V. 61. -P. 23−28.
- C-reactive protein levels and clinically important predictive outcomes in stable COPD patients / J.P. de Torres, E. Cordoba-Lanus, C. Lopez-Aguilar et al. // Eur. Respir. J. 2006. — V. 27. — P. 902−907.
- C-reactive protein levels and survival in patients with moderate to verysevere COPD / J.P. de Torres, V. Pinto-Plata, C. Casanova et al. // Chest. i2008.-V. 133.-P. 1336−1343.
- C-reactive protein: linking inflammation to cardiovascular complications / E.T. Yeh, H.V. Anderson, V. Pasceri et al. // Circulation. 2001. — V. 1041 -P. 974−975.
- Curtis, J.R. The assessment of health status among patients with COPD 7 J.R. Curtis, D.L. Patrick // Eur. Respir. J. 2003: — V. 21. — P. 36−45.
- Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Thi) and macrophage-stimulating cytokines / J. Frostegard, A.K. Ulfgren, P. Nyberg et al. // Atherosclerosis. 1999. — V. 145.-P. 33−43.
- Daily activity energy expenditure and mortality among older adults / T.M. Manini, J.E. Everhart, K.V. Patel et al. // JAMA. 2006. — V. 296. — Pi 171 179.
- Definition, epidemiology and natural’history of COPD / G. Viegi, F. Pistelli, D.L. Sherrill et al. // Eur. Respir. J. 2007. — V.30. — P. 993−1013.
- Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells / S.K. Venugopal, S. Devaraj, I. Yuhanna et al. // Circulation. 2002. — V. 106. — P. 1439−1441.
- Determinants of Different Dimensions of Disease Severity in Asthma and COPD. Pulmonary Function and Health-Related Quality of Life / H.A.H. Wijnhoven, D.M.W. Kriegsman, A.E. Hesselink et al. // Chest. 2001. — V. 119.-P. 1034−1042.
- Distance and oxygen desaturation during six-minute walk test as predictors of long-term mortality in patients with COPD / C. Casanova, C. Cote, J.M. Marin et al. // Chest. 2008. — V. 134. — P.746−752.
- Do GOLD stages of COPD severity really correspond to differences in health status / R. Antonelli-Incalzi, C. Imperiale, V. Bellia et al. // Eur. Respir. J. 2003. — V. 22. — P. 444−449.
- Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD / K. Nishimura, T. Izumi, M. Tsukino et al. // Chest. -2002.-V. 121.-P. 1434−1440.
- Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives / P. S. Wang, J. Avorn, M.A. Brookhart et al. // Hypertension. 2005. — V. 46. — P. 273−279.
- Effects of tiotropium on lung hyperinflation, dyspnea and exercise tolerance in COPD / D.E. ODonnell, T. Fluge, F. Gercen et al. // Eur. Respir. J. -2004. V. 23. — P. 832−840.
- Elevated CRP mark metabolic and functional impairment in advanced COPD / R. Broekhuizen, E.F. Wouters, E.C. Creutzberg et al. // Thorax. -2006.-V. 61.-P. 17−22.
- Endothelial interaction of neutrophils under flow in chronic obstructive pulmonary disease / I.S. Woolhouse, D.L. Bayley, P. Lalor et al. // Eur. Respir. J. 2005. — V. 25. — P. 612−617.
- Endothelin antagonism and interleukin-6 inhibition. attenuate the proatherogenic effects of C-reactive protein / S. Verma, S.H. Li, M.V. Badiwala et al. // Circulation. 2002. — V. 105. — P. 1890−1896.
- Enright, P.L. Reference equations for the six-minute walk in healthy adults / P.L. Enright, D.L. Sherrill // Am. J. Respir. Crit. Care Med. 1998. — V. 158. -P. 1384−1387.
- Eosinophilic and neutrophilic inflammation in asthma and chronic obstructive pulmonary disease / J.Y. Lacoste, J. Bousquet, P. Chanez et al. // J. Allergy Clin. Immunol. 1993. -V. 92. — P. 537−548.
- Eosinophilic inflammation in stable chronic obstructive pulmonary disease. Relationship with neutrophils and airway function / G. Balzano, F. Stefaneiii, C. Iorto et al. // Am. J. Respir. Crit. Care Med. 1999. — V. 160. -P. 1486−1492.
- Exercise training raises daily activity stronger than predicted from exercise capacity in patients with COPD / M. Behnke, A.R. Wewel, D. Kirsten et al. // Respir. Med. 2005. — V. 99. — P. 711−717.
- Ezzati, M. Estimates of global mortality attributable to smoking in 2000 / M. Ezzati, A.D. Lopez // Lancet. 2003. — V. 362. — P. 847−852.
- Fabbri, L.M. Chronic disease in the elderly: back to the future of internal medicine / L.M. Fabbri, R. Ferrari // Breathe. 2006. — V. 3. — P. 40−49.
- Fabbri, L.M. Complexity of patients with multiple chronic diseases Электронный ресурс. / L.M. Fabbri, K.F. Rabe // Proceedings of an ERS
- Research Seminar Rome, 2007 — Электрон, дан. — Режим доступа: www.ersnet.org/ers/lr/browse/default.aspx7id dossier=67 422.
- Fabbri, L.M. From COPD to chronic systemic inflammatory syndrome? / L.M. Fabbri, K.F. Rabe // Lancet. 2007. — V. 370. — P. 797−799.
- Factor analysis of risk variables associated with low-grade inflammation / D. Aronson, O. Avizohar, Y. Levy et al. // Atherosclerosis. 2008. — V. 200. -P. 206−212.
- Gan, W.Q. The interactions between cigarette smoking and reduced lung function on systemic inflammation / W.Q. Gan, S.F. Man, D.D. Sin // Chest. 2005. — V. 127. — P. 558−564.
- Gender differences in the association between C-reactive protein, lung function impairment, and COPD / I.S. Olafsdottir, T. Gislason, B. Thjodleifsson et al. // Int. J. Chron. Obstruct. Pulmon. Dis. 2007. — V. 2. -P. 635−642.
- Genetic determinants of C-reactive protein in COPD / C.P. Hersh, D.T. Miller, D.J. Kwiatkowski et al. // Eur. Respir. J. 2006. — V. 28. — P. 1156−1162.
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). NHLBI/WHO workshop report. Last updated 2008 Электронный ресурс. Электрон, дан. — Режим доступа: http://www.goldcopd.org.
- Handschin, С. The role of exercise and PGC-la in inflammation and chronic disease / C. Handschin, B.M. Spiegelman // Nature. 2008. — V. 454.-P. 463469.
- Health status deterioration in patients with chronic obstructive pulmonary disease / S. Spencer, P.M.A. Calverley, P. S. Burge et al. // Am. J. Respir. Crit. Care Med. 2001. — V. 163. — P. 122−128.
- Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease / A. Domingo-Salvany, R. Lamarca, M. Ferrer et al. // Am. J. Respir. Crit. Care Med. 2002. — V. 166. — P. 680 685.
- Health-related quality of life in COPD: why both disease-specific and generic measures should be used / C.P. Engstrom, L.O. Persson, S. Laesson et al И Eur. Respir. J. 2001. — V. 18. — P. 69−76.
- High-sensitive C-reactive protein is associated with reduced lung function in young adults / F. Rasmussen, D. Mikkelsen, R.J. Hancox et al. // Eur. Respir. J. -2009. -V. 33. P. 382−388.
- Hirschfield, G.M. C-reactive protein and cardiovascular disease: new insights from an old molecule / G.M. Hirschfield, M.B. Pepys // Q. J. Med. —2003.-V. 96.-P. 793−807.
- Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease / F. Whittom, J. Jobin, P.M. Simard et al. // Med. Sci Sports Exerc. 1998. — V. 301 — P. 1467−1474.
- Hogg, J.C. Infection and COPD / J.C. Hogg // Exp. Lung Res. 2005. -V. 31.-P. 72−73.
- Huiart, L. Cardiovascular morbidity and mortality in COPD / L. Huiart, P. Ernst, S. Suissa // Chest. 2005. — V. 128. — P. 2640−2646.
- Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population / W.L. Hutchinson, W. Koenig, M. Frohlich et al. // Clin. Chem. 2000. -V. 46. — P. 934−938.
- Impact of preventing exacerbations on deterioration of health status in COPD / S. Spencer, P.M. Calverley, P. S. Burge et al. // Eur. Respir. J.2004. V. 23. — P. 698−702.
- Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD / R. Casaburi, D. Kukafka, C.B. Cooper et al. // Chest. 2005. — V. 127. — P. 809−817.
- Improvements in resting inspiratory capacity and hyperinflation with tiotropium in COPD with increased static lung volumes / B.R. Celli, R. Zu Wallack, S. Wang et al. // Chest. -2003. -V. 124. P. 1743−1748.
- Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T-lymphocytes with FEY / T.C. 0JShaughnessy, T.W. Ansari, N.C. Barnes et al. // Am. J. Respir. Crit. Care Med. 1997.-V. 155.-P. 852−857.
- Inflammation markers predicting frailty and mortality in the elderly / M. De Martinis, C. Franceschi, D. Monti et al. // Exp. Mol. Pathol. 2006. -V. 80.-P. 219−227.
- Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects / S. Yende, G.W. Waterer, E.A. Tolley et al. // Thorax. 2006. — V. 61.-P. 10−16.
- Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease / V.l. Peinado, J.A. Barbera, P. Abate et al. // Am. J. Respir. Crit. Care Med. 1999. — V. 159. — P. 1605−1611.
- Inflammatory- response and body composition in chronic obstructive pulmonary disease / A.A. Bid- A.A. Lonescu, L.S. Nixon et al. // Am. J. Respir. Crit. Care Med. 2001.-V. 164.-P. 1414−1418.
- Interpretation of quality of life scores from the St. George’s Respiratory Questionnaire / M. Ferrer, C. Villasante, J. Alonso et al. // Eur. Respir. J. 2002. — V. 19. — P. 405−413.
- Interpretation of treatment changes in the 6-minute walk distance in patients with COPD / M.A. Puhan, M.J. Mador, U. Held et al. // Eur. Respir. J: 2008. — V. 32. — P. 637−643.
- Interpreting small differences in functional status: the six minute walk test in chronic lung disease patients / D.A. Redelmeier, A.M. Bayoumi, R.S. Goldstein et al. // Am. J. Respir. Crit. Care Med. 1997. — V. 155. — P. 1278−1282.
- Janson, C. Inflammation and lung damage / C. Janson, G. Boman // Eur. Respir. Monograph. 2000. — V. 15. — P. 272−287.
- Jones, P.W. St. George’s Respiratory Questionnaire: development, interpretation and use / P.W. Jones // Eur. Respir. Rev. — 2002. — V. 12. P. 63−64.
- Katsura, H. Usefulness of a linear analog scale questionnaire to measure health-related quality of life in elderly patients with chronic obstructive pulmonary disease / H. Katsura, K. Yamada, K. Kida // J. Am. Geriatr. Soc.-2003.-V. 51.-P. 1131−1135.
- Keatings, V. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma and normal subject / V. Keatings, P.J. Barnes // Am. J. Respir. Crit. Care Med. -1997.-V. 155.-P. 449—453.
- Kriegsman, D.M. Comorbidity of somatic chronic diseases and decline in physical functioning: the Longitudinal Aging Study Amsterdam / D.M. Kriegsman, D.J. Deeg, W.A. Stalman // J. Clin. Epidemiol. 2004. -V. 57. — P. 55−65.
- Leidy, N.K. An overview of health-related quality of life effects and outcomes in patients with COPD / N.K. Leidy, S.F. Anton, R.A. Berzon // Eur. Respir. Rev. 2002. — V. 12. — P. 61−62.
- Leukocyte counts and macrophage phenotypes in induced sputum and bronchoalveolar lavage fluid from normal subjects / C. Lensmar, G. Elmberger, G. Sandgren et al. // Eur. Respir. J. 1998. — V. 12. — P. 595 608.
- Longitudinal deteriorations in patients reported outcomes in patients with COPD / T. Oga, K. Nishimura, M. Tsukino et al. // Respir. Med. 2007. -V. 101.-P. 146−153.
- Lower limb activity and its determinants in chronic obstructive pulmonary disease / P.P. Walker, A. Burnett, P.W. Flavahan et al. // Thorax. 2008. — V. 8. — P. 683−689.
- Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins / G. Engstrom, P. Lind, B. Hedblad et al. // Circulation. 2002. — V. 106. — P. 2555−2560.
- Lusis, A.J. Atherosclerosis / A.J. Lusis // Nature. 2000. — V. 407. -P. 233−241.
- Mahler, D.A. How should health-related quality of life be assessed in patients with COPD / D.A. Mahler // Chest. 2000. — V. 117. — P. 54−57.
- Mai, H. Prevalence and diagnosis of severe pulmonary hypertension in patients with chronic obstructive pulmonary disease / H. Mai // Curr. Opin. Pulm. Med.-2007.-V. 13.-P. 114−119.
- Mallia, P. How viral infections cause exacerbation of airway diseases / P. Mallia, S.L. Johnston // Chest. 2006. — V. 130. — P. 1203−1210.
- Maltais, F. Skeletal muscles in- chronic airflow obstruction: why bother? / F. Maltais // Am. J. Respir. Crit. Care Med. 2003. — V. 168. — P. 916 -917.
- Man, S.F. COPD as a risk factor for cardiovascular morbidity and mortality / S.F. Man // Proc. Am. Thorax Soc. 2005. — V. 2. — P. 8−11.
- Mannino, D.M. Global burden of COPD: risk factors, prevalence, and future trends / D.M. Mannino, A.S. Buist // Lancet. 2007. — V. 370. — P. 765−773.
- Mannino, D.M. Lung function decline and outcomes in an elderly population / D.M. Mannino, K.J. Davis // Thorax. 2006. — V. 61. — P. 472 477.
- Morgan, M. Physical activity and exercise testing in COPD Электронный ресурс. / M. Morgan — Электрон, дан. — Режим доступа: http://www.az-air.com.
- Morley, J.E. Cachexia: pathophysiology and clinical relevance / J.E. Morley, D.R. Thomas, M.M. Wilson // Am. J. Clin. Nutr. 2006. — V. 83. -P. 735−743.
- Mortality after hospitalization for COPD / P. Almagro,.E. Calbo, A.O. de Echaguen et al. // Chest. 2002. — V. 121. — P. 1441−1448.
- Mortality in COPD: role of comorbidities / D.D. Sin, N.R. Anthonisen, J.B. Soriano et al. // Eur. Respir. J. 2006. — V. 28. — P. 12 451 257.
- Muscle weakness is related to utilization of health care resources in COPD patients / M. Decramer, R. Gosselink, Т. Troosters et al. // Eur. Respir. J. 1997. — V. 10. — P. 417−423.
- Nadel, J. The role of inflammatory cells in mucus secretion bronchial remodeling / J. Nadel // Rev. Mai. Respir. 1998. — V. 15. — P. 21−23.
- O’Byrne, K.J. Chronic immune activation and inflammation as the cause of malignancy / K.J. O’Byrne, A.G. Dalgleish // Br. J. Cancer. 2001. -V. 85.-P. 473−483.
- Occurrence and prognostic significance of ventricular arrhythmia is related to pulmonary function: a study from «men. born in 1914», Malmo, Sweden / G. Engstrom, P. Wollmer, B. Hedblad et al. // Circulation. 2001. -V. 103.-P. 3086−3091.
- OT)onnell, D.E. Lung mechanics in COPD: the role of tiotropium / D.E. (TDonnell // Eur. Respir. Rev. 2004. — V. 13. — P. 40−44.
- ODonnell, D.E. Dyspnea and activity limitation in COPD: mechanical factors / D.E. OT) onnell, P. Laveneziana // COPD. 2007. — V. 4. — P. 225 236.
- OTJonnell, D.E. Exertional breathlessness in patients wih chronic airflow limitation. The role of lung hyperinflation / D.E. O’Donnell, K.A. Webb//Am. Rev. Respir. Dis. 1993. — V. 148.-P. 1351−1357.
- Orozco-Levi, M. Structure and function of the respiratory muscles in patients with chronic obstructive pulmonary disease: impairment or adaptation? / M. Orozco-Levi // Eur. Respir. J. 2003. — V. 22. — P. 41−51.
- Outcomes for COPD pharmacological trials: from lung function to biomarkers / M. Cazzola, W. MacNee, F J. Martinez et al. // Eur. Respir. J. -2008. V. 31. — P. 416469.
- Paggiaro, P.L. Sputum induction / P.L. Paggiaro // Eur. Respir. J. -2002.-V. 20.-P. 3−8.
- Parameswaran, K. Altered respiratory physiology in obesity / K. Parameswaran, D.C. Todd, M. Soth // Can. Respir. J. 2006. — V. 13. — P. 203−210.
- Patterns of comorbidities in newly diagnosed COPD and asthma in primary care / J.B. Soriano, G.T. Visick, H. Muellerova et al. // Chest. -2005. V. 128. — P. 2099−2107.
- Pavord, I.D. Clinical application of assessment of airway inflammation using induced sputum / I.D. Pavord // Eur. Respir. J. — 2002. -V. 20.-P. 40−43.
- Peroxisome proliferator-activated receptors: a therapeutic target in COPD? / A.H. Remels, H.R. Gosker, P. Schrauwen et al. // Eur. Respir. J. -2008. — V. 31. P. 502−508.
- Physical activity and its determinants in severe chronic obstructive pulmonary disease / J. Garcia-Aymerich, M.A. Felez, J. Escarrabill et al. // Med. Sei Sports Exerc. 2004. — V. 36. — P. 1667−1673.
- Physical activity in patients with COPD / H. Watz, B. Waschki, T. Meyer et al. // Eur. Respir. J. 2009. — V. 33. — P. 262−272.
- Physiologie Responses to Incremental and Self-Paced Exercise in COPD / S. Turner, P. Eastwood, N. Cecins et al. // Chest. 2004. — V. 126. -P. 766−773.
- Predictive role of single diseases and their combination on recovery of balance and gait in disabled elderly patients / I. Di Fazio, S. Franzoni, G.B. Frisoni et al. // J. Am. Med. Dir. Assoc. 2006. — V. 7. — P. 208−211.
- Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation / A.M. Schols, P.B. Soeters, A. M: Dingemans et al.1 // Am. Rev. Respir. Dis. 1993. — V. 147. -P. 1151−1156.
- Prevalence and outcomes of diabetes, hypertension, and cardiovascular disease in chronic obstructive pulmonary disease / D.M. Mannino, D. Thorn, A. Swensen et al. // Eur. Respir. J. 2008. — V. 32. — P. 962−969.
- Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic and nonishemic cardiomyopathy / M. Shah, V. Hasselblad, M. Gheorgiadis et al. // Am. J. Cardiol. 2001. — V. 88. — P. 987−993.
- Prognostic value of nutritional status in chronic obstructive pulmonary disease / C. Landbo, E. Prescott, P. Lange et al. // Am. J. Respir. Crit. Care Med. 1999.-V. 160.-P. 1856−1861.
- Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study / H.J. Schunemann- J. Dorn, B J. Grant et al. // Chest. 2000. — V. 118. — P. 656 664.
- Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease / I.M. Osman, DJ. Godden, J.A. Friend et al. // Thorax. 1997. -V. 52. — P. 67−71.
- Quality of life measured with a generic instrument (Short Form-36) improves following pulmonary rehabilitation in patients with COPD / F.M. Boueri, B.L. Bucher-Bartelson, K.A. Glenn et al. // Chest. 2001. — V. 119. -P. 77−84.
- Quantifying physical activity in daily life with questionnaires and motion sensors in COPD / F. Pitta, T. Troosters, V.S. Probst et al. // Eur. Respir. J. 2006. — V. 27. — P. 1040−1055.
- Quantitating physical activity in COPD using a triaxial accelerometer / B.G. Steele, L. Holt, B. Belza et al. // Chest. 2000. — V. 117. — P. 13 591 367.
- Recent advances iniCOPD: pathophysiology, respiratory physiology and clinical aspects / A. Bourdin, P-R. Burgel, P. Chanez et al. // Eur. Respir. Rev. -2009.-V. 18. -P. 198−212.
- Recognising heart, failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study / F.H. Rutten, K.G. Moons, M.J. Cramer etal. // B.M.J. 2005. — V. 331.-P. 1379.
- Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population-based cohort study / J. Garcia-Aymerich, P. Lange, M. Benet et al. // Thorax. 2006. — V. 61. — P. 772−778.
- Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD / R.A. OT) onnell, C. Peebles, J.A. Ward et al. // Thorax. 2004. — V. 59. — P. 837−842.
- Relationship between pulmonary function and physical activity in daily life in patients with COPD / F. Pitta, M.Y. Takaki, N.H. Oliveira et al. // Respir. Med. 2008. — V. 102. — P. 1203−1207.
- Rennard, S.I. Clinical approach to patients with chronic obstructive pulmonary disease and cardivascular disease / S.I. Rennard // Proc. Am. Thorac Soc. 2005. -V. 2. — P. 94−100.
- Rennard, S.I. Inflammation in COPD: a link to systemic comorbidities / S. i: Rennard // Eur. Respir. Rev. 2007. — V. 16. — P: 91−97.
- Rennard, S.I. Pathophysiological mechanisms of COPD / S.I. Rennard // Eur. Respir. Rev. 1997. — V. 45. — P. 206−210.
- Ridker, P.M. C-reactive protein, inflammation, and coronary risk / P.M. Ridker, D.A. Morrow // Cardiol. Clin. 2003. — V. 21. — P. 315−325.
- Ross, R. Atherosclerosis an inflammatory disease / R. Ross // N. Engl. J. Med. — 1999. — V. 340. — P. 115−126.
- Sevenoaks, M.J. Chronic obstructive pulmonary disease, inflammation and comorbidity — a common inflammatory phenotype? / M.J. Sevenoaks, R.A. Stockley // Respir. Res. 2006. V. 7. — P. 70.
- SF-36 Health Survey Manuel and Interpretation Guide Linkoln, RI: Quality Metric Incorporated, 2000. — 150p.
- Sherbourne C. D, Stewart A.L., Wells K.B. Role functioning measures. In: Stewart A.L., Ware J.E. et al. Measuring functioning and well-being: The Medical Outcomes Study Approach. Durham, NC: Duke University Press., 1992.-P. 205−208.
- Shine, B. Solid phase radioimmunoassays for human C-reactive protein / B. Shine, F.C. de Beer, MB. Pepys // Clin. Chim. Acta 1981. -V. 117.-P. 13−23.
- Sin, D.D. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortalit / D.D. Sin, S.F. Man // Proc. Am. Thorac. Soc. 2005. — V. 2. — P. 8−11.
- Singh, S. Activity monitors can detect brisk walking in patients with chronic obstructive' pulmonary disease / S. Singh, M.D. Morgan // J. Cardiopulm. Rehabil. -2001. V. 21. -P: 143−148:
- Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease / A.G. Agusti, J. Sauleda, C. Miralles et al. // Am. J. Respir. Crit. Care Med. 2002. — V. 166. — P. 485−489.
- Skeletal muscle inflammation and nitric oxide in patients with COPD / M. Montes de Oca, S.H. Torres, J. De Sanctis et al. // Eur. Respir. J. 2005. -V. 26. — P.390−397.
- Spencer, S. Time course of recovery of health status following an infective exacerbation of chronic bronchitis / S. Spencer, P.W. Jones // Thorax. 2003. — V. — 58. — P. 589−593.
- Stages of disease severity and factors that effects the health status of patients with chronic obstructive pulmonary disease / T. Hajiro, K. Nishimura, M. Tsukino et al. // Respir. Med. 2000. — V. 94. — P. 841−846.
- Standardization of spirometry, 1994 Update / American Thoracic Society // Am. J. Respir. Crit. Care Med: 1995. — V. 152. — P. 1107−1136.
- Stockley, R.A. Neutrophils and the pathogenesis in COPD / R.A. Stockley//Chest.-2002.-V. 121.-P. 151−155.
- Systemic effects of chronic obstructive pulmonary disease / A.G.N. Agusti, A. Noguera, J. Sauleda et al. // Eur. Respir. J. 2003. — V. 21. — P. 347−360,
- Systemic inflammation and decline in lung function in a general population: a prospective study / A.W. Fogarty, S. Jones, J.R. Britton et al. // Thorax.-2007.-V. 62.-P. 515−520.
- Systemic inflammation in patients with COPD and pulmonary hypertension / P. Joppa, D. Petrasova, B. Stancak et al. // Chest. 2006. — V. 130.-P. 326−333.
- Taichman, D.B. Epidemiology of pulmonary arterial- hypertension / D.B. Taichman, J. Mandel // Clin. Chest Med. 2007. — V. 28. — P. 1−2:
- Teramoto, S. The role of nuclear factor-kappa B activation in airway inflammation following adenovirus infection and COPD / S. Teramoto, H. Kume//Chest.-2001.-V. 119.-P. 1294−1295.
- The 6-min walk distance in healthy subjects: reference standards from seven countries / C. Casanova, B.R. Celli, P. Barria et al. // Eur. Respir. J. — 2011.-V. 37.-P. 150−156.
- The 6-min walk distance: change over time and value as a predictor of survival in severe COPD / V.M. Pinto-Plata, C. Cote, H. Cabral et al. // Eur. Respir. J. 2004. -V. 23. — P. 28−33.
- The 6-min walking distance: long-term follow up in patients with COPD / C. Casanova, C.G. Cote, J.M. Marin et al. // Eur. Respir. J. 2007. -V. 29.-P. 535−540.
- The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease / B.R. Celli, C.G. Cote, J.M. Marin et al. //N. Engl. J. Med. 2004. -V. 350. — P. 1005−1012.
- The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies / M. Poulain, M. Doucet, G.C. Major et al. // C.M.A.J. 2006. — V. 174. — P. 1293−1299.
- The effectiveness of the Visual Analogue Scale 8 in measuring health-related quality of life for COPD patients / O. Nishiyama, H. Taniguchi, Y. Kondon et al. // Respir.Med. 2000. — V. 94. — P. 1192−1199.
- The influence of COPD on health-related quality of life independent of the influence of comorbidity / J.G. van Manen, P J. Bindels, F.W. Dekker et al. // J. Clin. Epidemiol. 2003. — V. 56. — P. 1177−1184.
- The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes / D.A. Mahler, D.H. Weinberg, C.K. Wells et al. // Chest. 1984 — V. 85. — P. 751−758.
- The nature of small-airway obstruction in chronic obstructive pulmonary disease / J.C. Hogg, F. Chu, S. Utokaparch et al. // N. Engl. J. Med. -2004. -V. 350. P. 2645−2653.
- The nutritional enhancement of exercise training in COPD. A randomized, controlled trial / M.C. Steiner, R.L. Barton, S.J. Singh et al. // Thorax. -2003. -V. 58. P. 745−751.
- The relation of C-reactive protein levels to total and cardiovascular mortality in older U.S. women / J.A. Tice, W. Browner, R.P. Tracy et al. // Am. J. Med.-2001.-V. 114.-P. 199−205.
- Validation and comparison of reference equations for the 6-min walk distance test / C.G. Cote, C. Casanova, J.M. Marin et al. // Eur. Respir. J. -2008.-V. 31.-P. 571−578.
- Variables related to increased mortality following out-patient pulmonary rehabilitation / D.A. Gerardi, L. Lovett, M.L. Benoit-Connors et al. // Eur. Respir. J. 1996. — V. 9. — P. 431-^35.
- Veeramachaneni, S.B. Pathogenesis of bacterial exacerbations of COPD / S.B. Veeramachaneni, S. Sethi // COPD. 2006. — V. 3. — P. 109 115.
- Ventilatory and metabolic adaptations to walking and cycling in patients with COPD / P. Palange, S. Forte, P. Onorati et al. // J. Appl. Physiol.-2000.-V. 88.-P. 1715−1720.
- Verma, S. C-reactive protein and atherothrombosis beyond a biomarker: an actual partaker of lesion formation / S. Verma, E.T. Yeh // Am. J. Physiol. Regul. Integr. Comp. Physiol. — 2003. — V. 285. — P. 12 531 256.
- Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease / A.M. Schols, J. Slangen, L. Volovics et al. // Am. J. Respir. Crit. Care Med. -1998. -V. 157. -P. 1791−1797.
- What Quality of life? / The WHOQOL Group // World Health Forum. 1996. — V. 17.-P. 354−356.
- Why Quality of Life measures should be used in the treatment of patients with respiratory illnesses / P.W. Jones, F.H. Quirk, C.M. Baveystock et al. // Monaldi Arch. Dis. Chest. 1994. — V. 49. — P. 79−82.
- Wouters, E.F.M. Chronic obstructive pulmonary disease. 5: systemic effects of COPD / E.F.M. Wouters // Thorax. 2002. — V. 57. — P. 10 671 070.
- Wouters, E.F.M. The systemic face of airway diseases: the role of C-reactive protein / E.F.M. Wouters // Eur. Respir. J. — 2006. V. 27. — P. 877−879.
- Wright, J.G. The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy / J.G. Wright, J.W. Christman // Am. J. Respir. Med. 2003. — V. 2. — P. 211−219.
- Yan, Z.Q. Innate immunity, macrophage activation, and atherosclerosis I Z.Q. Yan, G.K. Hansson // Immunol. Rev. 2007. — V. 219.-P. 187−203.
- Zigmond, A.S. The hospital Anxiety and Depression scale / A.S. Zigmond, R.P. Snaith // Acta Psychiatr. Scand. 1983. — V. 67. — P. 361 370.
- ZuWallack, R. The effects of nutritional depletion on health status / R. ZuWallack // J. Nutr. Metab. Chron. Respir. Dis. 2003. — V. 24. — P. 132 141.